Cargando…
A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence
Clinically, the treatments against asthma like β(2) agonist focus on controlling the symptoms rather than inhibiting recurrence radically. This study aims to evaluate the efficacy and mechanism of a potent Chinese prescription Yu-Ping-Feng-San (YPFS) against asthma recurrence. We here established an...
Autores principales: | Bao, Kaifan, Yuan, Weiyuan, Zhou, Yijing, Chen, Yanyan, Yu, Xuerui, Wang, Xiaoyu, Jia, Zhirong, Yu, Xi, Wang, Xiaotong, Yao, Lu, Wang, Siqi, Xu, Yifan, Zhang, Yuheng, Zheng, Jie, Hong, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006455/ https://www.ncbi.nlm.nih.gov/pubmed/32076408 http://dx.doi.org/10.3389/fphar.2019.01698 |
Ejemplares similares
-
Screening Active Components from Yu-Ping-Feng-San for Regulating Initiative Key Factors in Allergic Sensitization
por: Shen, Dandan, et al.
Publicado: (2014) -
Mechanism of YuPingFeng in the Treatment of COPD Based on Network Pharmacology
por: Yin, Yunhong, et al.
Publicado: (2020) -
Yu ping feng san for pediatric allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials
por: Liao, Yong, et al.
Publicado: (2021) -
Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma
por: Xue, Lingna, et al.
Publicado: (2021) -
Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD
por: Yang, Zhong-Shan, et al.
Publicado: (2016)